Categories Earnings, Health Care
Bausch Health Companies Inc. (NYSE: BHC): Q4 2019 Earnings Snapshot
— Bausch Health Companies Inc. (NYSE: BHC) reported a loss of $4.30 per share for the fourth quarter of 2019, compared to a loss of $0.98 per share last year, vs. $1.15 per share loss expected.
— Net loss for the quarter was $1.516 billion, compared to a loss of $344 million a year earlier
— December-quarter revenues increased 5% annually to $2.22 billion, vs. $2.2 billion expected
— Revenue of Bausch + Lomb/International, the main business segment, grew 3% annually; Salix segment revenue was up 21%
— Received FDA approval for ARAZLO Lotion for the topical treatment of acne vulgaris in young adults
— Raised capital allocation for research and development by 14% in fiscal 2019, compared to last year
— Expects full-year 2020 revenues to be in the range of $8.65 billion to $8.85 billion
— Looking for adjusted EBITDA in the range of $3.50 billion to $3.65 billion for fiscal 2020
Most Popular
What to look for when Hewlett Packard (HPE) reports Q4 2024 results
Information technology company Hewlett Packard Enterprise (NYSE: HPE) is actively innovating its product portfolio to better align with the AI-driven transformation currently sweeping the industry. In recent quarters, the company's
What to expect when Dollar General (DG) reports Q3 2024 earnings
Shares of Dollar General Corporation (NYSE: DG) rose over 1% on Wednesday. The stock has dropped 38% over the past three months. The discount retailer is slated to report its earnings
Campbell Soup (CPB) to report Q1 earnings on Dec. 4. Here’s what to expect
Campbell Soup Company (NASDAQ: CPB) is gearing up to publish first-quarter results next week. The company recently rechristened itself, dropping “soup” from the name and assuming a new identity after
